May 7, 2001
Collaboration forms new cancer center
By Sarah Goodwin
Childrens Healthcare of Atlanta and the School of Medicine announced recently the collaboration of two formerly independent programs, to be known henceforth as the AFLAC Cancer Center and Blood Disorders Service.
Now in its sixth year as the main sponsor, AFLAC is a significant supporter
of the newest national pediatric cancer and blood disorders program, establishing
a shared vision for pediatric cancer and blood disorders research, enhanced
bedside treatment and innovative patient support services.
Committed to advancements in pediatric cancer research, clinical care
and supportive services, the centers efforts will be focused on
some of the most important priorities in pediatric hematology/oncology
today: leukemia and other blood cancers, stem-cell transplantation, experimental
therapy, childhood cancer etiology, neuro-oncology and sickle cell disease.
The AFLAC Cancer Center coordinates the strengths of the pediatric hematology/oncology
programs of Childrens Healthcare (formerly Egleston and Scottish
Rite childrens hospitals). As one entity, the center is one of the
top childrens cancer centers in the country based on case volume.
The program is enhanced by its collaborative relationship with the School
of Medicine and the Winship Cancer Institute. Emory and Winship will enable
the AFLAC Cancer Center to provide clinical care to children and adolescents,
participate in national clinical trials and perform laboratory and epidemiological
researchall with the goal of improving standards of care and treatment
outcomes in pediatric hematology/oncology.
William Woods will serve as both chief medical officer of the center
and division director for pediatric hematology/oncology/stem cell transplantation
in the medical school. A world-recognized leader in pediatric hematology/oncology,
Woods also serves on the executive committee of the nations most
important pediatric cancer research organization, Childrens Oncology
The AFLAC Cancer Center has a patient volume comparable to or exceeding any of the nations top childrens cancer centers, which, when coupled with Emorys research relationship, means that pediatric cancer therapy can move quickly from the laboratory to the patients bedside, Woods said.
The new AFLAC Cancer Center and Blood Disorders Service of Childrens
Healthcare of Atlanta will enable us to make faster and greater advancements
than one institution could do alone.
In noting AFLACs role, Woods said, Quite simply, AFLACs
involvement goes well beyond financial support. AFLACs senior management
has been supportive in so many aspects, energizing the AFLAC Cancer Center
staff, our scope of work and our bold agenda for research and treatment.
In addition to the companys corporate commitment, AFLAC CEO Dan Amos and thousands of associates and employees have made personal contributions to the center. Through gifts from AFLACs Field Force Fund, independent representatives across the United States have donated more than $2 million, funding enhanced programs such as the Stoudemire Fund for Psycho-social Support and the Cancer Survivor Clinic. In addition, through AFLACs successful national advertising campaign, proceeds from Internet sales of the stuffed duck that quacks AFLAC are being given to the AFLAC Cancer Center.